| Product Code: ETC9959201 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Alzheimer's Disease Diagnostic Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Alzheimer's Disease Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Alzheimer's Disease Diagnostic Market - Industry Life Cycle |
3.4 United States (US) Alzheimer's Disease Diagnostic Market - Porter's Five Forces |
3.5 United States (US) Alzheimer's Disease Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Alzheimer's Disease Diagnostic Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 United States (US) Alzheimer's Disease Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Alzheimer's disease in the United States |
4.2.2 Growing awareness and early diagnosis initiatives |
4.2.3 Technological advancements in diagnostic tools and techniques |
4.3 Market Restraints |
4.3.1 High cost associated with diagnostic procedures |
4.3.2 Limited reimbursement policies for Alzheimer's disease diagnostics |
4.3.3 Regulatory challenges and stringent approval processes for new diagnostic technologies |
5 United States (US) Alzheimer's Disease Diagnostic Market Trends |
6 United States (US) Alzheimer's Disease Diagnostic Market, By Types |
6.1 United States (US) Alzheimer's Disease Diagnostic Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Nervous System, 2021- 2031F |
6.1.4 United States (US) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Examination, 2021- 2031F |
6.1.5 United States (US) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Genetic Testing, 2021- 2031F |
6.1.6 United States (US) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Minor Mental State Examination, 2021- 2031F |
6.1.7 United States (US) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Brain Imaging, 2021- 2031F |
6.2 United States (US) Alzheimer's Disease Diagnostic Market, By End Users |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.3 United States (US) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.4 United States (US) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.2.5 United States (US) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.2.6 United States (US) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Academic Research Center, 2021- 2031F |
7 United States (US) Alzheimer's Disease Diagnostic Market Import-Export Trade Statistics |
7.1 United States (US) Alzheimer's Disease Diagnostic Market Export to Major Countries |
7.2 United States (US) Alzheimer's Disease Diagnostic Market Imports from Major Countries |
8 United States (US) Alzheimer's Disease Diagnostic Market Key Performance Indicators |
8.1 Average age of diagnosis for Alzheimer's disease patients |
8.2 Number of healthcare facilities offering Alzheimer's disease diagnostic services |
8.3 Adoption rate of innovative diagnostic technologies in the market |
9 United States (US) Alzheimer's Disease Diagnostic Market - Opportunity Assessment |
9.1 United States (US) Alzheimer's Disease Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Alzheimer's Disease Diagnostic Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 United States (US) Alzheimer's Disease Diagnostic Market - Competitive Landscape |
10.1 United States (US) Alzheimer's Disease Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Alzheimer's Disease Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here